the significant changes include primary surgery without preoperative cesium , primary treatment based on grade without regard to uterine size , modified radical hysterectomy for g3 tumors , pelvic radiotherapy for clear cell carcinoma confined to the pelvis regardless of depth of invasion , cytoxan , adriamycin , and cis-platinum for papillary serous tumors , and postoperative vaginal cuff cesium for g2 and g3 tumors not requiring pelvic radiotherapy .
C0042149
uterine
C2987682
radical